(VIANEWS) – Shares of Bio-Rad (NYSE: BIO) fell by a staggering 25.27% in 30 days from $755.61 to $564.67 at 19:49 EST on Thursday, after five successive sessions in a row of losses. NYSE is falling 0.52% to $16,152.12, after three consecutive sessions in a row of losses.
Bio-Rad’s last close was $564.67, 32.19% below its 52-week high of $832.70.
Today’s last reported volume for Bio-Rad is 262169 which is 90.42% above its average volume of 137675.
Bio-Rad’s sales growth is 2.3% for the ongoing quarter and a decline by 7.5% for the next. The company’s growth estimates for the present quarter and the next is a negative 18.7% and a negative 20.9%, respectively.
Year-on-year quarterly revenue growth grew by 33.4%, now sitting on 2.88B for the twelve trailing months.
Bio-Rad’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.92%, a negative 1.37%, and a positive 1.49%, respectively.
Bio-Rad’s highest amplitude of average volatility was 0.92% (last week), 1.73% (last month), and 1.49% (last quarter), respectively.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
Bio-Rad’s stock is considered to be overbought (>=80).
Bio-Rad’s Stock Yearly Top and Bottom Value
Bio-Rad’s stock is valued at $564.67 at 19:49 EST, way under its 52-week high of $832.70 and way higher than its 52-week low of $507.22.
Bio-Rad’s Moving Average
Bio-Rad’s worth is way below its 50-day moving average of $750.37 and way under its 200-day moving average of $700.87.
More news about Bio-Rad (BIO).